Anders Carlsten

1.2k total citations
30 papers, 922 citations indexed

About

Anders Carlsten is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anders Carlsten has authored 30 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Geriatrics and Gerontology, 14 papers in Economics and Econometrics and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anders Carlsten's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Pharmaceutical studies and practices (11 papers) and Pharmaceutical Economics and Policy (9 papers). Anders Carlsten is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Pharmaceutical studies and practices (11 papers) and Pharmaceutical Economics and Policy (9 papers). Anders Carlsten collaborates with scholars based in Sweden. Anders Carlsten's co-authors include Karolina Andersson Sundell, Max Petzold, Margda Wærn, Anders Ekedahl, Jonny Olsson, Johan Fastbom, Christian Sonesson, Knut Lönnroth, Anna K. Jönsson and Jonas Ranstam and has published in prestigious journals such as PLoS ONE, BMC Public Health and Patient Education and Counseling.

In The Last Decade

Anders Carlsten

29 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Carlsten Sweden	19	384	316	221	167	152	30	922
Balamurugan Tangiisuran Malaysia	15	237 0.6×	529 1.7×	152 0.7×	123 0.7×	73 0.5×	58	1.1k
Amanda Lavan Ireland	13	312 0.8×	621 2.0×	150 0.7×	60 0.4×	83 0.5×	38	1.0k
Anders Ekedahl Sweden	17	125 0.3×	286 0.9×	127 0.6×	85 0.5×	105 0.7×	40	770
Arnold Zermansky United Kingdom	17	436 1.1×	935 3.0×	132 0.6×	131 0.8×	64 0.4×	27	1.3k
Catharina C. M. Schuiling‐Veninga Netherlands	19	147 0.4×	175 0.6×	201 0.9×	299 1.8×	161 1.1×	64	1.3k
Cecilia Bernsten Sweden	15	189 0.5×	495 1.6×	153 0.7×	150 0.9×	35 0.2×	21	843
Joshua Borus United States	9	163 0.4×	864 2.7×	310 1.4×	60 0.4×	80 0.5×	19	1.7k
Anna Renom‐Guiteras Spain	19	316 0.8×	654 2.1×	139 0.6×	434 2.6×	140 0.9×	44	1.4k
Jane R. Mort United States	15	179 0.5×	449 1.4×	69 0.3×	173 1.0×	49 0.3×	35	897
Julie Stokes Australia	14	220 0.6×	579 1.8×	111 0.5×	148 0.9×	109 0.7×	20	877

Countries citing papers authored by Anders Carlsten

Since Specialization

Citations

This map shows the geographic impact of Anders Carlsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Carlsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Carlsten more than expected).

Fields of papers citing papers by Anders Carlsten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Carlsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Carlsten. The network helps show where Anders Carlsten may publish in the future.

Co-authorship network of co-authors of Anders Carlsten

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Carlsten. A scholar is included among the top collaborators of Anders Carlsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Carlsten. Anders Carlsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gyllensten, Hanna, Katja M. Hakkarainen, Staffan Hägg, et al.. (2014). Economic Impact of Adverse Drug Events – A Retrospective Population-Based Cohort Study of 4970 Adults. PLoS ONE. 9(3). e92061–e92061. 49 indexed citations

Gyllensten, Hanna, Clas Rehnberg, Anna K. Jönsson, et al.. (2013). Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey. BMJ Open. 3(6). e002574–e002574. 45 indexed citations

Gyllensten, Hanna, Anna K. Jönsson, Clas Rehnberg, & Anders Carlsten. (2012). How are the Costs of Drug-Related Morbidity Measured?. Drug Safety. 35(3). 1–1. 16 indexed citations

Vilhelmsson, Andreas, Tommy Svensson, Anna Meeuwisse, & Anders Carlsten. (2012). Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association. BMC Pharmacology and Toxicology. 13(1). 19–19. 15 indexed citations

Gyllensten, Hanna, Katja M. Hakkarainen, Anna K. Jönsson, et al.. (2012). Modelling drug-related morbidity in Sweden using an expert panel of pharmacists’. International Journal of Clinical Pharmacy. 34(4). 538–546. 10 indexed citations

Hakkarainen, Katja M., et al.. (2012). Modelling drug-related morbidity in Sweden using an expert panel of physicians. European Journal of Clinical Pharmacology. 68(9). 1309–1319. 7 indexed citations

Vilhelmsson, Andreas, Tommy Svensson, Anna Meeuwisse, & Anders Carlsten. (2011). What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association. PubMed. 11(1). 16–16. 20 indexed citations

Lesén, Eva, Anders Carlsten, Ingmar Skoog, et al.. (2011). Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study. International Psychogeriatrics. 23(8). 1270–1277. 5 indexed citations

Olsson, Jonny, et al.. (2010). Quality of Drug Prescribing in Elderly People in Nursing Homes and Special Care Units for Dementia. Clinical Drug Investigation. 30(5). 289–300. 65 indexed citations

10.

Lesén, Eva, Karolina Andersson Sundell, Max Petzold, & Anders Carlsten. (2010). Socioeconomic determinants of psychotropic drug utilisation among elderly: a national population-based cross-sectional study. BMC Public Health. 10(1). 118–118. 28 indexed citations

11.

Sundell, Karolina Andersson, Anders Carlsten, & Tove Hedenrud. (2009). Prescribing behaviour after the introduction of decentralized drug budgets: Is there an association with employer and type of care facility?. Scandinavian Journal of Primary Health Care. 27(2). 117–122. 8 indexed citations

12.

Carlsten, Anders & Margda Wærn. (2009). Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly?. BMC Geriatrics. 9(1). 20–20. 42 indexed citations

13.

Lesén, Eva, Max Petzold, Karolina Andersson Sundell, & Anders Carlsten. (2009). To what extent does the indicator “concurrent use of three or more psychotropic drugs” capture use of potentially inappropriate psychotropics among the elderly?. European Journal of Clinical Pharmacology. 65(6). 635–642. 20 indexed citations

14.

Sundell, Karolina Andersson, Max Petzold, Peter Allebeck, & Anders Carlsten. (2008). Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years. BMC Health Services Research. 8(1). 50–50. 25 indexed citations

15.

Olsson, Jonny, et al.. (2006). Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scandinavian Journal of Primary Health Care. 25(1). 9–14. 88 indexed citations

16.

Sundell, Karolina Andersson, et al.. (2006). Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals. Health Policy. 81(2-3). 376–384. 69 indexed citations

17.

Sundell, Karolina Andersson, Max Petzold, Christian Sonesson, Knut Lönnroth, & Anders Carlsten. (2006). Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?. Health Policy. 79(2-3). 231–243. 43 indexed citations

18.

Sundell, Karolina Andersson, Christian Sonesson, Max Petzold, Anders Carlsten, & Knut Lönnroth. (2004). What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiology and Drug Safety. 14(5). 341–348. 94 indexed citations

19.

Aneblom, Gunilla, Cecilia Stålsby Lundborg, Anders Carlsten, Karin Eurenius, & Tanja Tydén. (2003). Emergency contraceptive pills over-the-counter: practices and attitudes of pharmacy and nurse-midwife providers. Patient Education and Counseling. 55(1). 129–135. 24 indexed citations

20.

Carlsten, Anders, Margda Wærn, Anders Ekedahl, & Jonas Ranstam. (2001). Antidepressant medication and suicide in Sweden. Pharmacoepidemiology and Drug Safety. 10(6). 525–530. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact